-The Telegraph New Delhi: Foreign corporations have created over 247,000 jobs through research and development (R&D) investments in India over the past decade, but most of the activities appear relatively unimportant with little long-term gains , researchers have said. The study, described as the first comprehensive assessment of foreign direct investment (FDI) in R&D, has challenged suggestions by Indian science policy makers and foreign corporations a decade ago that turning India into...

-The Hindu Those opposing GM crops ignore scientific evidence of their harmlessness and are depriving the nation of the wider benefits of agri-biotechnology It is unfortunate that the technical group appointed by the Supreme Court has chosen to stick with its recommendation for an indefinite moratorium on GM crop trials. There is fierce opposition from activists even to the introduction of the Biotechnology Regulatory Authority Bill (BRAI) in Parliament, meant to evolve...

-Live Mint For the first time, tribal communities in India will have a say in implementation of projects that affect them In the last six months, two key milestones have been reached in India around the protection of Adivasi rights. The first milestone was a ruling by Supreme Court in April which gave Adivasi communities in the Niyamgiri hills of Orissa the final say on plans by a subsidiary of Vedanta...

-Tehelka.com There are few figures from the adivasi community in India who have made a bigger dent in the collective imagination of the country than Dayamani Barla. The "iron lady of Jharkhand" has been instrumental in articulating adivasi struggles against displacement and deprivation on national and international platforms. Dayamani, who was recently imprisoned in Jharkhand for her involvement in the Nagri people's movement, has won the first Ellen L Lutz Indigenous...

-The Economic Times To ensure access to healthcare for all, India must harness innovation in discovering drugs, in developing therapeutics and in delivering affordable healthcare. It is in the light of these facts that one should evaluate the impact of the Indian Supreme Court's ruling in the case involving patent protection for Novartis AG's cancer drug, Glivec. Glivec was the first-of-its-kind cancer drug for leukaemia patients with patent protection in nearly 40...